Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): Is a clinical benefit still achievable?

Autor: Carlini, P. *, Frassoldati, A., De Marco, S., Casali, A., Ruggeri, E.M., Nardi, M., Papaldo, P., Fabi, A., Paoloni, F., Cognetti, F.
Zdroj: In Annals of Oncology November 2001 12(11):1539-1543
Databáze: ScienceDirect